BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Albiin N. MRI of Focal Liver Lesions. Curr Med Imaging Rev. 2012;8:107-116. [PMID: 23049491 DOI: 10.2174/157340512800672216] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Chehab MA, Brinjikji W, Copelan A, Venkatesan AM. Navigational Tools for Interventional Radiology and Interventional Oncology Applications. Semin Intervent Radiol 2015;32:416-27. [PMID: 26622105 DOI: 10.1055/s-0035-1564705] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
2 Hayes T, Smyth E, Riddell A, Allum W. Staging in Esophageal and Gastric Cancers. Hematology/Oncology Clinics of North America 2017;31:427-40. [DOI: 10.1016/j.hoc.2017.02.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
3 Yi D, Wen-Ping W, Lee WJ, Meloni MF, Clevert DA, Cristina Chammas M, Tannapfel A, Forgione A, Dietrich CF. Hepatocellular carcinoma in the non-cirrhotic liver. Clin Hemorheol Microcirc 2021. [PMID: 34842182 DOI: 10.3233/CH-211309] [Reference Citation Analysis]
4 Jansen MJA, Kuijf HJ, Veldhuis WB, Wessels FJ, Viergever MA, Pluim JPW. Automatic classification of focal liver lesions based on MRI and risk factors. PLoS One. 2019;14:e0217053. [PMID: 31095624 DOI: 10.1371/journal.pone.0217053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
5 Hoffmann R, Rempp H, Schraml C, Schwenzer N, Grözinger G, Blumenstock G, Rothgang E, Pereira PL, Claussen CD, Clasen S. Diffusion-weighted imaging during MR-guided radiofrequency ablation of hepatic malignancies: analysis of immediate pre- and post-ablative diffusion characteristics. Acta Radiol 2015;56:908-16. [DOI: 10.1177/0284185114545148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xi IL, Wu J, Guan J, Zhang PJ, Horii SC, Soulen MC, Zhang Z, Bai HX. Deep learning for differentiation of benign and malignant solid liver lesions on ultrasonography. Abdom Radiol (NY) 2021;46:534-43. [PMID: 32681268 DOI: 10.1007/s00261-020-02564-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
7 Kim MJ, Han SY, Baek YH, Lee SW, Kwon HJ. A case of focal nodular hyperplasia with growth progression during pregnancy. Clin Mol Hepatol 2014;20:392-7. [PMID: 25548746 DOI: 10.3350/cmh.2014.20.4.392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Elbanna KY, Kielar AZ. Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis. Clin Liver Dis (Hoboken) 2021;17:159-64. [PMID: 33868658 DOI: 10.1002/cld.1089] [Reference Citation Analysis]
9 Jiang L, Tan H, Panje CM, Yu H, Xiu Y, Shi H. Role of 18F-FDG PET/CT Imaging in Intrahepatic Cholangiocarcinoma. Clin Nucl Med. 2016;41:1-7. [PMID: 26402131 DOI: 10.1097/rlu.0000000000000998] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 5.8] [Reference Citation Analysis]
10 Dohan A, Gavini J, Placé V, Sebbag D, Vignaud A, Herbin C, Hamzi L, Boudiaf M, Soyer P. T2-weighted MR imaging of the liver: Qualitative and quantitative comparison of SPACE MR imaging with turbo spin-echo MR imaging. European Journal of Radiology 2013;82:e655-61. [DOI: 10.1016/j.ejrad.2013.07.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
11 Zhang G, Li W, Wang G, He X, Xu L, Wang S, Peng W. Multimode tumor ablation therapy induced different diffusion and microvasculature related parameters change on functional magnetic resonance imaging compared to radiofrequency ablation in liver tumor: An observational study. Medicine (Baltimore) 2020;99:e20795. [PMID: 32590762 DOI: 10.1097/MD.0000000000020795] [Reference Citation Analysis]
12 Chiorean L, Caraiani C, Radziņa M, Jedrzejczyk M, Schreiber-dietrich D, Dietrich CF. Vascular phases in imaging and their role in focal liver lesions assessment. CH 2016;62:299-326. [DOI: 10.3233/ch-151971] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
13 Liu M, Chen J, Huang R, Huang J, Li L, Li Y, Qin M, Qin W, Nong H, Ding K. Imaging features of intrahepatic cholangiocarcinoma mimicking a liver abscess: an analysis of 8 cases. BMC Gastroenterol 2021;21:427. [PMID: 34772340 DOI: 10.1186/s12876-021-02002-1] [Reference Citation Analysis]
14 Di Pietropaolo M, Briani C, Pilozzi E, Carbonetti F, David V, Iannicelli E. Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature. J Gastrointest Cancer 2015;46:421-5. [PMID: 25894634 DOI: 10.1007/s12029-015-9715-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Lantinga MA, Gevers TJ, Drenth JP. Evaluation of hepatic cystic lesions. World J Gastroenterol 2013; 19(23): 3543-3554 [PMID: 23801855 DOI: 10.3748/wjg.v19.i23.3543] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 49] [Article Influence: 8.9] [Reference Citation Analysis]
16 Shahrouki P, Felker ER, Raman SS, Jeong WK, Lu DS, Finn JP. Steady-state ferumoxytol-enhanced MRI: early observations in benign abdominal organ masses and clinical implications. Abdom Radiol (NY) 2021. [PMID: 34689252 DOI: 10.1007/s00261-021-03271-w] [Reference Citation Analysis]
17 Kim Y, Amini N, He J, Margonis GA, Weiss M, Wolfgang CL, Makary M, Hirose K, Spolverato G, Pawlik TM. National trends in the use of surgery for benign hepatic tumors in the United States. Surgery. 2015;157:1055-1064. [PMID: 25769697 DOI: 10.1016/j.surg.2015.01.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
18 Agostini A, Kircher MF, Do RK, Borgheresi A, Monti S, Giovagnoni A, Mannelli L. Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions. Semin Roentgenol 2016;51:317-33. [PMID: 27743568 DOI: 10.1053/j.ro.2016.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
19 Benkert T, Mugler JP 3rd, Rigie DS, Sodickson DK, Chandarana H, Block KT. Hybrid T2 - and T1 -weighted radial acquisition for free-breathing abdominal examination. Magn Reson Med 2018;80:1935-48. [PMID: 29656522 DOI: 10.1002/mrm.27200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Alenezi AO, Krishna S, Mendiratta-Lala M, Kielar AZ. Imaging and Management of Liver Cancer. Semin Ultrasound CT MR 2020;41:122-38. [PMID: 32446427 DOI: 10.1053/j.sult.2019.12.002] [Reference Citation Analysis]
21 Hallinan JT, Alsaif HS, Wee A, Venkatesh SK. Magnetic resonance elastography of liver: influence of intravenous gadolinium administration on measured liver stiffness. Abdom Imaging. 2015;40:783-788. [PMID: 25331568 DOI: 10.1007/s00261-014-0275-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
22 Elmohr MM, Chernyak V, Sirlin CB, Elsayes KM. Liver Imaging Reporting and Data System Comprehensive Guide: MR Imaging Edition. Magn Reson Imaging Clin N Am 2021;29:375-87. [PMID: 34243924 DOI: 10.1016/j.mric.2021.05.012] [Reference Citation Analysis]
23 Garmendia S, Mantione D, Alonso-de Castro S, Jehanno C, Lezama L, Hedrick JL, Mecerreyes D, Salassa L, Sardon H. Polyurethane based organic macromolecular contrast agents (PU-ORCAs) for magnetic resonance imaging. Polym Chem 2017;8:2693-701. [DOI: 10.1039/c7py00166e] [Cited by in Crossref: 23] [Article Influence: 4.6] [Reference Citation Analysis]
24 Luetkens JA, Kupczyk PA, Doerner J, Fimmers R, Willinek WA, Schild HH, Kukuk GM. Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol. Eur Radiol 2015;25:3207-13. [PMID: 25903709 DOI: 10.1007/s00330-015-3736-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
25 Bouomrani S, Kilani I, Nouma H, Slama A, Beji M. [Non fibrolamellar hepatocellular carcinoma on a healthy liver]. Pan Afr Med J 2014;18:155. [PMID: 25419293 DOI: 10.11604/pamj.2014.18.155.2762] [Reference Citation Analysis]
26 Gatos I, Tsantis S, Karamesini M, Spiliopoulos S, Karnabatidis D, Hazle JD, Kagadis GC. Focal liver lesions segmentation and classification in nonenhanced T2-weighted MRI. Med Phys 2017;44:3695-705. [PMID: 28432822 DOI: 10.1002/mp.12291] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
27 Borusewicz P, Stańczyk E, Kubiak K, Spużak J, Glińska-Suchocka K, Jankowski M, Nicpoń J, Podgórski P. Liver enhancement in healthy dogs after gadoxetic acid administration during dynamic contrast-enhanced magnetic resonance imaging. Vet J 2018;235:16-21. [PMID: 29704934 DOI: 10.1016/j.tvjl.2018.03.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Colagrande S, Castellani A, Nardi C, Lorini C, Calistri L, Filippone A. The role of diffusion-weighted imaging in the detection of hepatic metastases from colorectal cancer: A comparison with unenhanced and Gd-EOB-DTPA enhanced MRI. Eur J Radiol. 2016;85:1027-1034. [PMID: 27130067 DOI: 10.1016/j.ejrad.2016.02.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
29 Bertino G, Ardiri A, Demma S, GiuseppeCalvagno S, Toro A, Basile E, Campagna D, Ferraro G, Frazzetto E, Proiti M. Rare benign tumors of the liver: still rare? J Gastrointest Cancer. 2014;45:202-217. [PMID: 24510731 DOI: 10.1007/s12029-014-9580-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mohamed E, Adiamah A, Dunn WK, Higashi Y, Cameron IC, Gomez D. Outcome of indeterminate liver lesions on computed tomography in patients with colorectal cancer. Ann R Coll Surg Engl 2018;100:382-7. [PMID: 29692186 DOI: 10.1308/rcsann.2018.0070] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
31 Caraiani C, Yi D, Petresc B, Dietrich C. Indications for abdominal imaging: When and what to choose? J Ultrason 2020;20:e43-54. [PMID: 32320166 DOI: 10.15557/JoU.2020.0008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Donato H, França M, Candelária I, Caseiro-Alves F. Liver MRI: From basic protocol to advanced techniques. Eur J Radiol 2017;93:30-9. [PMID: 28668428 DOI: 10.1016/j.ejrad.2017.05.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
33 Demin AM, Pershina AG, Ivanov VV, Nevskaya KV, Shevelev OB, Minin AS, Byzov IV, Sazonov AE, Krasnov VP, Ogorodova LM. 3-Aminopropylsilane-modified iron oxide nanoparticles for contrast-enhanced magnetic resonance imaging of liver lesions induced by Opisthorchis felineus. Int J Nanomedicine 2016;11:4451-63. [PMID: 27660439 DOI: 10.2147/IJN.S111880] [Cited by in Crossref: 25] [Cited by in F6Publishing: 3] [Article Influence: 4.2] [Reference Citation Analysis]
34 Acharya UR, Koh JEW, Hagiwara Y, Tan JH, Gertych A, Vijayananthan A, Yaakup NA, Abdullah BJJ, Bin Mohd Fabell MK, Yeong CH. Automated diagnosis of focal liver lesions using bidirectional empirical mode decomposition features. Comput Biol Med 2018;94:11-8. [PMID: 29353161 DOI: 10.1016/j.compbiomed.2017.12.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
35 Lee JC, Yan K, Lee SK, Yang W, Chen MH. Focal Liver Lesions: Real-time 3-Dimensional Contrast-Enhanced Ultrasonography Compared With 2-Dimensional Contrast-Enhanced Ultrasonography and Magnetic Resonance Imaging. J Ultrasound Med 2017;36:2015-26. [PMID: 28646628 DOI: 10.1002/jum.14268] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
36 Salem AI, Winslow ER. Current technical aspects of oncological hepatic surgery. Hepatobiliary & Pancreatic Diseases International 2017;16:147-54. [DOI: 10.1016/s1499-3872(16)60147-9] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
37 Hoekstra LT, Bieze M, Erdogan D, Roelofs JJ, Beuers UH, van Gulik TM. Management of giant liver hemangiomas: an update. Expert Rev Gastroenterol Hepatol. 2013;7:263-268. [PMID: 23445235 DOI: 10.1586/egh.13.10] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
38 De Robertis R, Tinazzi Martini P, Demozzi E, Dal Corso F, Bassi C, Pederzoli P, D’Onofrio M. Diffusion-weighted imaging of pancreatic cancer. World J Radiol 2015; 7(10): 319-328 [PMID: 26516428 DOI: 10.4329/wjr.v7.i10.319] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
39 Salarian M, Turaga RC, Xue S, Nezafati M, Hekmatyar K, Qiao J, Zhang Y, Tan S, Ibhagui OY, Hai Y, Li J, Mukkavilli R, Sharma M, Mittal P, Min X, Keilholz S, Yu L, Qin G, Farris AB, Liu ZR, Yang JJ. Early detection and staging of chronic liver diseases with a protein MRI contrast agent. Nat Commun 2019;10:4777. [PMID: 31664017 DOI: 10.1038/s41467-019-11984-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
40 Piché D, Tavernaro I, Fleddermann J, Lozano JG, Varambhia A, Maguire ML, Koch M, Ukai T, Hernández Rodríguez AJ, Jones L, Dillon F, Reyes Molina I, Mitzutani M, González Dalmau ER, Maekawa T, Nellist PD, Kraegeloh A, Grobert N. Targeted T1 Magnetic Resonance Imaging Contrast Enhancement with Extraordinarily Small CoFe2O4 Nanoparticles. ACS Appl Mater Interfaces 2019;11:6724-40. [PMID: 30688055 DOI: 10.1021/acsami.8b17162] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
41 Kim R, Lee JM, Shin CI, Lee ES, Yoon JH, Joo I, Kim SH, Hwang I, Han JK, Choi BI. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Eur Radiol. 2016;26:1808-1817. [PMID: 26373763 DOI: 10.1007/s00330-015-4005-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 7.6] [Reference Citation Analysis]
42 Pankaj Jain T, Kan WT, Edward S, Fernon H, Kansan Naider R. Evaluation of ADCratio on liver MRI diffusion to discriminate benign versus malignant solid liver lesions. Eur J Radiol Open 2018;5:209-14. [PMID: 30480057 DOI: 10.1016/j.ejro.2018.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]